Recital 57

Health data users who benefit from access to datasets provided for under this Regulation could enrich the data in those datasets with various corrections, annotations and other improvements, for instance by supplementing missing or incomplete data, thus improving the accuracy, completeness or quality of the data in the datasets. Health data users should be encouraged to report critical errors in datasets to health data access bodies. To support the improvement of the initial database and further use of the enriched dataset, Member States should be able to establish rules for the processing and the use of electronic health data containing improvements related to the processing of those data. The improved dataset should be made available free of charge to the original health data holder together with a description of the improvements. The health data holder should make the new dataset available, unless it provides a justified notification to the health data access body for not doing so, for instance in cases in which the enrichment by the health data user is of low quality. It should be ensured that non-personal electronic health data are available for secondary use. In particular, pathogen genomic data hold significant value for human health, as shown during the COVID-19 pandemic during which timely access to and sharing of such data proved to be essential for the rapid development of detection tools, medical countermeasures and responses to public health threats. The greatest benefit from pathogen genomics efforts will be achieved when public health and research processes share datasets and cooperate to inform and improve each other.